AdvisorShares Psychedelics ETF

PSIL is a Global Equities ETF. The Fund is an actively managed exchange-traded fund ( ETF ) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and (ii) derivatives that have economic characteristics similar to such securities. The Fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The Fund invests in exchange-listed equity securities, including common and preferred stock of U.S. and foreign mid, small and micro-capitalization companies, and in total return swaps intended to provide exposure to such companies.

Yes, PSIL is actively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

No, PSIL is not passively managed. It is actively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on PSIL is 0.0381%. This is the percent change in the value of PSIL over the most recent 1-month period. The 3-month return on PSIL is -0.0475%. This is the percent change in the value of PSIL over the most recent 3-month period.

The standard deviation of PSIL for the past year is 0.3965%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to PSIL include IXJ, SMH, and URA.

ETFs correlated to PSIL include ARKG, ARKK, and TARK.

ETFs that are inversely correlated to PSIL include BTAL, SARK, and HDGE.